The $3.6M injection provides short-term liquidity for a micro-cap with a $3M market cap, but the potential dilution from up to 15.8M new warrants (exercisable at $0.60) is enormous relative to current shares outstanding. Monitor for stockholder approval of the warrants and any subsequent exercise. The reduced exercise price of $0.48 for existing warrants suggests existing holders were unwilling to exercise at higher levels, signaling weak conviction in the stock's value.
Price Chart
Executive Summary
AIM ImmunoTech closed a warrant exercise inducement transaction on May 8, 2026, receiving ~$3.6M in gross proceeds from the cash exercise of 7,451,920 existing warrants at a reduced price of $0.48/share. In exchange, the company issued new Class H warrants to purchase up to 14,903,840 shares at $0.60/share, plus placement agent warrants for 894,230 shares at $0.60/share. This is a dilutive capital raise for a micro-cap company with a $3M market cap, providing near-term cash but massively increasing potential share count.
Key Financial Metrics
Key Facts
- Closed inducement transaction on May 8, 2026
- Received aggregate gross proceeds of approximately $3.6 million
- Holders exercised existing warrants for 7,451,920 shares at $0.48 per share (reduced exercise price)
- Issued new Class H warrants to purchase up to 14,903,840 shares at $0.60 per share
- Issued placement agent warrants to purchase 894,230 shares at $0.60 per share
- Placement agent received ~$285,000 cash fee (8.0% of gross proceeds), $50,000 expenses, and ~$26,000 management fee
- New warrants have 5-year term, exercisable after stockholder approval
- Placement agent warrants have exercise price equal to 125% of the reduced exercise price ($0.60)
- Company market cap is only ~$3M, making the potential dilution from new warrants extremely significant
Financial Impact
Gross proceeds of ~$3.6M from cash exercise of 7.45M shares at $0.48/share. Potential future dilution from up to 15.8M new warrants (14.9M Class H + 0.89M placement agent) at $0.60/share, which is massive relative to a $3M market cap.
Risk Factors
- Massive potential dilution from up to 15.8M new warrants relative to current ~$3M market cap
- Reduced exercise price ($0.48) indicates existing warrant holders needed a discount to exercise
- Company is pre-revenue biotech with no approved products, relying on dilutive financing
- Placement agent warrants with piggyback registration rights could lead to accelerated selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-022499 |
| Document: form8-k.htm | 0001493152-26-022499 |
| Document: 0001493152-26-022499-index-headers.html | 0001493152-26-022499 |
| Document: 0001493152-26-022499-index.html | 0001493152-26-022499 |
| Document: 0001493152-26-022499.txt | 0001493152-26-022499 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 25d ago | DEF 14A | $0.1877 | awaiting T+20 | — | $0.1600 (−14.76%) |
Sep 22, 2026 4w ago | Press Release | $0.2156 $0.1662 | ▼ −22.91% | ▼ −22.35% | $0.1600 (−25.79%) |
Sep 14, 2026 5w ago | 8-K | $0.2100 | awaiting T+20 | — | $0.1600 (+23.81%) |
Aug 11, 2026 10w ago | 8-K | $0.2500 $0.2332 | ▼ −6.72% | ▼ −5.66% | $0.1600 (−36.00%) |
Aug 10, 2026 10w ago | 8-K | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 10, 2026 10w ago | Press Release | $0.2630 | awaiting T+20 | — | $0.1600 (+39.16%) |
Aug 5, 2026 11w ago | 8-K | $0.2800 $0.2346 | ▼ −16.21% | ▼ −15.61% | $0.1600 (−42.86%) |
Aug 3, 2026 11w ago | Press Release | $0.2600 $0.2260 | ▼ −13.08% | ▼ −14.31% | $0.1600 (−38.46%) |
Jun 24, 2026 17w ago | EFFECT | $0.3740 $0.2534 | ▲ +32.25% | ▲ +34.18% | $0.1600 (+57.22%) |
Jun 18, 2026 18w ago | S-1 | $0.3799 $0.2730 | ▲ +28.14% | ▲ +28.67% | $0.1600 (+57.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers